| scholarly article | Q13442814 |
| P50 | author | Elzbieta Gocek | Q59158098 |
| P2093 | author name string | George P Studzinski | |
| Chang-Gong Liu | |||
| Xiuping Liu | |||
| Xuening Wang | |||
| P2860 | cites work | MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression | Q36498054 |
| The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways | Q37420518 | ||
| Erythropoietin: a hormone with multiple functions | Q37862940 | ||
| MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. | Q38305314 | ||
| CCAAT/enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development | Q38321977 | ||
| MicroRNAs 221 and 222 bypass quiescence and compromise cell survival | Q39496704 | ||
| Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations. | Q39780907 | ||
| MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes | Q39926867 | ||
| Regulation of p27Kip1 by miRNA 221/222 in glioblastoma | Q40089204 | ||
| Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications | Q40107588 | ||
| Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. | Q40446996 | ||
| miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells. | Q43127538 | ||
| Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells | Q43635650 | ||
| Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells | Q44167310 | ||
| Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates | Q44271562 | ||
| AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells | Q46945328 | ||
| Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. | Q50910177 | ||
| A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol | Q69838614 | ||
| 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells | Q72025020 | ||
| Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c | Q73661196 | ||
| Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3 | Q73749865 | ||
| MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis | Q79849727 | ||
| Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation | Q80120303 | ||
| Acute myelogenous leukemia | Q83889468 | ||
| The nuclear RNase III Drosha initiates microRNA processing | Q24295234 | ||
| Ribonuclease activity and RNA binding of recombinant human Dicer | Q24315047 | ||
| Bim: a novel member of the Bcl-2 family that promotes apoptosis | Q24532974 | ||
| MicroRNA maturation: stepwise processing and subcellular localization | Q24534359 | ||
| Fast and effective prediction of microRNA/target duplexes | Q24537313 | ||
| miRBase: microRNA sequences, targets and gene nomenclature | Q24538656 | ||
| The microRNA.org resource: targets and expression | Q24650094 | ||
| MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis | Q24654905 | ||
| miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements | Q24656666 | ||
| Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. | Q25256835 | ||
| Nuclear export of microRNA precursors | Q27860686 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim | Q28201672 | ||
| Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia | Q28282977 | ||
| Natural selection on human microRNA binding sites inferred from SNP data | Q31071445 | ||
| Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells | Q31910647 | ||
| MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3 | Q33583422 | ||
| Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3 | Q33622844 | ||
| hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells | Q33622860 | ||
| The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. | Q33622877 | ||
| Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage | Q34515285 | ||
| MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle | Q34698100 | ||
| Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells | Q34723871 | ||
| Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells | Q34739775 | ||
| Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer | Q34803786 | ||
| Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation | Q35958335 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| myeloid leukemia | Q11688946 | ||
| apoptotic process | Q14599311 | ||
| leukemia | Q29496 | ||
| P304 | page(s) | 6230-6239 | |
| P577 | publication date | 2011-08-04 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis | |
| P478 | volume | 71 |
| Q36946756 | A SNP in pri-miR-10a is associated with recurrent spontaneous abortion in a Han-Chinese population |
| Q37992691 | Apoptosis and microRNA aberrations in cancer |
| Q90084053 | Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes |
| Q34031476 | Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. |
| Q37434990 | BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia |
| Q38860132 | Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells. |
| Q28070220 | Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis |
| Q38874859 | DNA Repair in Despair-Vitamin D Is Not Fair. |
| Q33731157 | Detection of 1α,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing |
| Q30417482 | Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer |
| Q90416874 | Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) |
| Q38209574 | Epigenetic perspectives on cancer chemotherapy response |
| Q36138538 | Extraskeletal actions of vitamin D. |
| Q38140001 | Hematological malignancies: role of miRNAs and their in silico aspects |
| Q37163718 | Hoxb8 regulates expression of microRNAs to control cell death and differentiation. |
| Q36508530 | Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D |
| Q38794721 | Keep Harm at Bay: Oxidative Phosphorylation Induces Nrf2-Driven Antioxidant Response Via ERK5/MEF2/miR-23a Signaling to Keap-1 |
| Q38802454 | Major apoptotic mechanisms and genes involved in apoptosis |
| Q36492992 | Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. |
| Q34576525 | MiR-24 promotes the survival of hematopoietic cells |
| Q34700577 | MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma |
| Q92786509 | MiR-32-5p influences high glucose-induced cardiac fibroblast proliferation and phenotypic alteration by inhibiting DUSP1 |
| Q36816367 | MicroRNA and cancer chemoprevention |
| Q36488217 | MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. |
| Q39160607 | MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells |
| Q85460422 | MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia |
| Q27013740 | MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune |
| Q27011401 | MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis |
| Q38938169 | New insights into vitamin D anticancer properties: focus on miRNA modulation. |
| Q38166375 | Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players |
| Q35554311 | Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis |
| Q38213627 | Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy |
| Q28482247 | Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction |
| Q90218021 | Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen |
| Q64053408 | Prenatal epigenetics diets play protective roles against environmental pollution |
| Q26781203 | Regulation of Bim in Health and Disease |
| Q38610901 | Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer |
| Q26799596 | The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy |
| Q38085104 | The emerging role of MicroRNAs in the regulation of gene expression by nutrients |
| Q42063012 | The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. |
| Q46061011 | The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer |
| Q39796064 | The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts. |
| Q34413846 | The role of vitamin D in reducing cancer risk and progression |
| Q36941178 | The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites |
| Q28071427 | Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs |
| Q34624695 | Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue |
| Q27015808 | Vitamin D and microRNAs in bone |
| Q34621641 | Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. |
| Q35781387 | miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells |
| Q39247434 | miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin |
| Q41859748 | miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer |
| Q38917523 | miRNA expression in human intestinal Caco-2 cells is comparably regulated by cis- and trans-fatty acids |
| Q47375547 | microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview |
| Q37018743 | microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report |
Search more.